Breckenridge Pharmaceutical, Inc. is a privately-held pharmaceutical marketing, research and development company that was founded in 1983. We market a broad range of generic prescription products in many therapeutic categories.
The Breckenridge label is recognized by Chains, Managed Care Accounts, Wholesalers, Distributors, the Federal Government, as well as Retail Pharmacies nationwide.
We market over 60 products in a variety of dosage forms including: Tablets, Capsules, Soft Gel Capsules, Liquids, Suspensions, Oral Powders, and Ophthalmics. Our pipeline includes:Nasal Sprays, Injectables, Transdermals, and Topicals.
Breckenridge, with company offices in Berlin, CT - Boca Raton, FL and New York City - has 30 approved Abbreviated New Drug Applications (ANDA's) and 42 ANDA's that have been filed and are pending for approval from the Food and Drug Administration (FDA).
we create opportunity